Physician adenoma detection rates and risk of post-colonoscopy colorectal cancer in a sequential screening programme: a retrospective cohort study.

IF 2.6 Q2 GASTROENTEROLOGY & HEPATOLOGY
Li Xie, Wenhong Wang, Guanglu Zhang, Lizhong Zhao, Huan Zhang, Hai Qin, Weituo Zhang, Mingqing Zhang, Biyun Qian, Xipeng Zhang
{"title":"Physician adenoma detection rates and risk of post-colonoscopy colorectal cancer in a sequential screening programme: a retrospective cohort study.","authors":"Li Xie, Wenhong Wang, Guanglu Zhang, Lizhong Zhao, Huan Zhang, Hai Qin, Weituo Zhang, Mingqing Zhang, Biyun Qian, Xipeng Zhang","doi":"10.1136/bmjgast-2024-001623","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Long-term colorectal cancer (CRC) monitoring is common in Asia, but assessing colonoscopy effectiveness through adenoma detection rates (ADRs) remains uncommon. This study aimed to identify potential associations between ADR and risk of post-colonoscopy CRC (PCCRC).</p><p><strong>Methods: </strong>This retrospective, longitudinal, observational study included participants (aged 40-74 years) with initial positive results and subsequent colonoscopy recruited from a community-based, multicentre, CRC screening programme from January 2012 to December 2022 in Tianjin, China. ADR was defined as the proportion of colonoscopies in which at least one adenoma was detected at the provider level. The primary outcome was PCCRC, defined as any CRC diagnosed 6 months after initial colonoscopy. ADR groups were categorised according to quartile distribution (<42%, 42%-55%, 55%-64% and >64%) or dichotomised as at or above vs below the median for statistical analyses. PCCRC incidence rates were expressed as the number of events per 1000 person-years.</p><p><strong>Results: </strong>Among 9957 included participants, 116 PCCRC cases were detected in 33 881 person-years of follow-up. PCCRC incidence rates per 1000 person-years were 4.34, 3.76, 2.62 and 2.69 from the lowest to the highest ADR group, respectively. ADR was significantly inversely associated with PCCRC risk. Participants in the highest ADR group had 49% lower risk of PCCRC than those in the low ADR group (adjusted HR 0.51, 95% CI 0.29 to 0.88). Multivariate-adjusted restricted cubic spline analyses identified a linear dose-response relationship between ADR and PCCRC risk.</p><p><strong>Conclusions: </strong>This study illustrates the relationship between endoscopist competence, as measured by ADR, and CRC risk after colonoscopy, which can guide assessment of monitoring programmes.</p>","PeriodicalId":9235,"journal":{"name":"BMJ Open Gastroenterology","volume":"12 1","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12603712/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjgast-2024-001623","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Long-term colorectal cancer (CRC) monitoring is common in Asia, but assessing colonoscopy effectiveness through adenoma detection rates (ADRs) remains uncommon. This study aimed to identify potential associations between ADR and risk of post-colonoscopy CRC (PCCRC).

Methods: This retrospective, longitudinal, observational study included participants (aged 40-74 years) with initial positive results and subsequent colonoscopy recruited from a community-based, multicentre, CRC screening programme from January 2012 to December 2022 in Tianjin, China. ADR was defined as the proportion of colonoscopies in which at least one adenoma was detected at the provider level. The primary outcome was PCCRC, defined as any CRC diagnosed 6 months after initial colonoscopy. ADR groups were categorised according to quartile distribution (<42%, 42%-55%, 55%-64% and >64%) or dichotomised as at or above vs below the median for statistical analyses. PCCRC incidence rates were expressed as the number of events per 1000 person-years.

Results: Among 9957 included participants, 116 PCCRC cases were detected in 33 881 person-years of follow-up. PCCRC incidence rates per 1000 person-years were 4.34, 3.76, 2.62 and 2.69 from the lowest to the highest ADR group, respectively. ADR was significantly inversely associated with PCCRC risk. Participants in the highest ADR group had 49% lower risk of PCCRC than those in the low ADR group (adjusted HR 0.51, 95% CI 0.29 to 0.88). Multivariate-adjusted restricted cubic spline analyses identified a linear dose-response relationship between ADR and PCCRC risk.

Conclusions: This study illustrates the relationship between endoscopist competence, as measured by ADR, and CRC risk after colonoscopy, which can guide assessment of monitoring programmes.

Abstract Image

Abstract Image

Abstract Image

医师腺瘤检出率和结肠镜检查后结直肠癌的风险:一项回顾性队列研究。
目的:结直肠癌(CRC)的长期监测在亚洲很常见,但通过腺瘤检出率(adr)评估结肠镜检查的有效性仍然不常见。本研究旨在确定不良反应与结肠镜后结直肠癌(PCCRC)风险之间的潜在关联。方法:这项回顾性、纵向、观察性研究纳入了从2012年1月至2022年12月中国天津社区、多中心CRC筛查项目中招募的初始阳性结果和随后结肠镜检查的参与者(40-74岁)。ADR被定义为在提供者水平上至少检测到一种腺瘤的结肠镜检查比例。主要结局为PCCRC,定义为首次结肠镜检查后6个月诊断出的任何CRC。ADR组根据四分位数分布(64%)进行分类,或根据高于或低于中位数进行二分类,以进行统计分析。PCCRC发病率表示为每1000人年发生的事件数。结果:在纳入的9957名参与者中,在33881人年的随访中发现了116例PCCRC病例。从ADR最低组到ADR最高组,PCCRC发病率分别为每1000人年4.34、3.76、2.62和2.69。ADR与PCCRC风险呈显著负相关。ADR最高组的参与者发生PCCRC的风险比低ADR组的参与者低49%(调整后HR 0.51, 95% CI 0.29至0.88)。多变量调整限制性三次样条分析确定了ADR与PCCRC风险之间的线性剂量-反应关系。结论:本研究阐明了内镜医师能力(以不良反应衡量)与结肠镜检查后结直肠癌风险之间的关系,这可以指导监测方案的评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Open Gastroenterology
BMJ Open Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
5.90
自引率
3.20%
发文量
68
审稿时长
2 weeks
期刊介绍: BMJ Open Gastroenterology is an online-only, peer-reviewed, open access gastroenterology journal, dedicated to publishing high-quality medical research from all disciplines and therapeutic areas of gastroenterology. It is the open access companion journal of Gut and is co-owned by the British Society of Gastroenterology. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Publishing procedures are built around continuous publication, publishing research online as soon as the article is ready.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书